๐
Fulvestrant Mylan
fulvestrant
Breast Neoplasms
โ
Authorised
Generic
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Fulvestrant is indicated for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women: not previously treated with endocrine therapy, or with disease relapse on or after adjuvant anti-estrogen therapy, or disease progression on antiestrogen therapy.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/fulvestrant-mylan